Braveheart Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Braveheart Bio and other ETFs, options, and stocks.About BRVE
Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor.
CEOTravis Murdoch
CEOTravis Murdoch
Employees—
Employees—
HeadquartersSan Francisco, California
HeadquartersSan Francisco, California
Founded2024
Founded2024
Employees—
Employees—
BRVE Key Statistics
Market cap2.62B
Market cap2.62B
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume539.55K
Average volume539.55K
High today$29.50
High today$29.50
Low today$27.47
Low today$27.47
Open price$27.78
Open price$27.78
Volume2.02M
Volume2.02M
52 Week high$32.00
52 Week high$32.00
52 Week low$18.00
52 Week low$18.00
Stock Snapshot
Braveheart Bio(BRVE) stock is priced at $28.76, giving the company a market capitalization of 2.62B.
As of 2026-09-19, Braveheart Bio(BRVE) stock has fluctuated between $27.47 and $29.50. The current price stands at $28.76, placing the stock +4.7% above today's low and -2.5% off the high.
Braveheart Bio(BRVE) shares are trading with a volume of 2.02M, against a daily average of 539.55K.
In the last year, Braveheart Bio(BRVE) shares hit a 52-week high of $32.00 and a 52-week low of $18.00.
In the last year, Braveheart Bio(BRVE) shares hit a 52-week high of $32.00 and a 52-week low of $18.00.
People also own
Based on the portfolios of people who own BRVE. This list is generated using Robinhood data, and it’s not a recommendation.